A study testing two diets to help people with type 2 diabetes lose weight and improve health in Northern Lebanon

Applying intervention mapping to develop an intervention for promoting weight loss and diabetes remission in individuals with type 2 diabetes mellitus living in Northern Lebanon: a randomized control trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN99204002

Enrollment

Registered

2026-01-14

Start date

2026-02-02

Completion date

Unknown

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine

Interventions

This is a two-phase (weight-loss diet through low-carb and med diets, and weight-maintenance phase using a customized mobile app) parallel-group randomized controlled trial conducted among adults with

aged 18–65 years, BMI =25 kg/m², disease duration =6 years, treated exclusively with oral anti-diabetic medications) will be randomly allocated to one of two intervention arms. Arm 1: Moderately low-

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18–65 years with T2DM 2. BMI =25 kg/m² 3. Exclusively on oral anti-diabetic medications 4. Disease duration of 6 years or less

Exclusion criteria

Exclusion criteria: 1. Renal failure 2. Cancer 3. Mental problems 4. Insulin use 5. Diabetes for more than 6 years

Design outcomes

Secondary

Measure	Time frame
Measured at baseline and every 3 months: 1. Lipid profile (HDL, LDL, triglycerides, total cholesterol) and C-reactive protein (CRP) as an inflammatory marker, measured using blood tests 2. Diabetes knowledge assessed using diabetes knowledge questionnaire 3. Physical activity assessed using the International Physical Activity Questionnaire (IPAQ) 4. Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI) 5. Psychological stress assessed using the Perceived Stress Scale (PSS) 6. Medication adherence assessed using the Morisky–Green–Levine (MGL) scale 7. Dietary intake and adherence assessed using 24-hour dietary recalls at each dietetic visit and the Mediterranean Diet Adherence Scale at baseline, after 3 months, and at the end of the intervention	—

Measure

Time frame

Measured at baseline and every 3 months: 1. Lipid profile (HDL, LDL, triglycerides, total cholesterol) and C-reactive protein (CRP) as an inflammatory marker, measured using blood tests 2. Diabetes knowledge assessed using diabetes knowledge questionnaire 3. Physical activity assessed using the International Physical Activity Questionnaire (IPAQ) 4. Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI) 5. Psychological stress assessed using the Perceived Stress Scale (PSS) 6. Medication adherence assessed using the Morisky–Green–Levine (MGL) scale 7. Dietary intake and adherence assessed using 24-hour dietary recalls at each dietetic visit and the Mediterranean Diet Adherence Scale at baseline, after 3 months, and at the end of the intervention

—

Countries

Lebanon

Contacts

Public ContactJanot Ayoub

janot.ayoub@maastrichtuniversity.nl+961 (0)3558792

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 23, 2026